Skip to main content
. 2023 Aug 20;43(8):1259–1267. [Article in Chinese] doi: 10.12122/j.issn.1673-4254.2023.08.01

表 1.

两组COVID-19相关ARDS重症患者在进行倾向性得分匹配前的临床特征

Clinical characteristics between two groups in critically ill patients with COVID-19 before propensity score matching

Items Total(n=199) Control group (n=164) Sivelestat group(n=35) P
MAP: Mean arterial pressure; SCr: Serum creatinine; ALT: Alanine aminotransferase; CRP: C-reactive protein; PCT: Procalcitonin; IL-6: Interleukin- 6; NT- proBNP: N- terminal pro-B- type natriuretic peptide; CRRT: Continuous renal replacement therapy; ECMO: Extracorporeal membrane oxygenation. aThe worst values within the first 24 h after ICU admission were recorded; bThe values on ICU discharge were recorded.
Using daysb 6.00[4.50, 8.50]
    Age (years)b 70.0 [53.5, 79.0] 70.0 [53.0, 80.0] 69 [59.0, 78.0] 0.649
Gender [n (%)]b 0.755
    Male 138(69.3) 115(70.1) 23(65.7)
    Female 61(30.7) 49(29.9) 12(34.3)
Comorbidities [n (%)]b
    Hypertension 108(58.1) 91(60.3) 17(48.6) 0.283
    Diabetes 79(42.5) 67(44.4) 12(34.3) 0.369
    Congestive heart failure 64(34.4) 53(35.1) 11(31.4) 0.83
    Chronic Pulmonary disease 35(18.8) 30(19.9) 5(14.3) 0.602
    Chronic renal disease 50(26.9) 39(25.8) 11(31.4) 0.644
    Liver disease 31(16.7) 23(15.2) 8(22.9) 0.401
    Cerebrovascular disease 34(18.4) 25(16.7) 9(25.7) 0.316
    Tumor 36(19.4) 31(20.5) 5(14.3) 0.545
APACHE IIa 24.0 [18.0, 30.0] 23.0 [17.0, 30.0] 24.0 [19.5, 30.0] 0.496
Medication [n (%)]b
    Paxlovid 94(50.8) 77(51.3) 17(48.6) 0.915
    Ambavirumab 40(21.6) 34(22.7) 6(17.1) 0.626
    Romesimab 39(21.1) 33(22) 6(17.1) 0.686
Vital sign and Laboratory valuesa
    Heart rate (min) 93.7 [82.1, 107.8] 94.0 [82.5, 105.2] 90.0 [80.2, 113.0] 0.935
    MAP (mmHg) 88.5 [76.7, 101.0] 89.0 [79.0, 101.7] 83 [68.2, 95.5] 0.083
    Respiratory rate (min) 12.0 [10.0, 14.0] 12.0 [10.0, 14.0] 13 [10.5, 15.0] 0.059
    SPpO2 88.0 [80.0, 94.0] 89.0 [80.0, 95.0] 87 [79.5, 91.0] 0.222
    PaO2 (mmHg) 88.5 [68.0, 125.0] 90.9 [68.9, 127.7] 78.9 [66.6, 104.5] 0.159
    PaCO2 (mmHg) 37.7 [33.0, 43.7] 37.6 [32.8, 43.2] 39 [33.2, 45.6] 0.569
    PaO2/FiO2 179 [111, 285] 193 [112, 307] 132 [101, 189] 0.033
    Lactate (mmol/L) 1.5 [1.0, 2.5] 1.5 [1.0, 2.5] 1.4 [1.0, 2.5] 0.832
    White blood cell (×109/L) 9.40 [6.4, 14.2] 9.7 [6.6, 14.0] 8.4 [5.9, 14.6] 0.297
    Hemoglobin (g/dL) 95.0 [74.5, 120.0] 94.0 [71.0, 120.0] 106 [87.0, 120.0] 0.082
    Platelets (×109/L) 153.0 [106.5, 219.0] 153.0 [102.0, 219.0] 152.0 [128.2, 215.2] 0.351
    SCr (mg/dL) 141.0 [74.0, 296.50] 146.5 [74.0, 293.0] 98.0 [76.0, 412.0] 0.506
    ALT(U/L) 35.0 [23.5, 74.0] 34.00 [22.0, 67.00] 54.00 [33.00, 90.00] 0.058
    Albumin (g/L) 31.9 [27.98, 34.62] 32.2 [27.6, 34.8] 31.1 [28.6, 34.1] 0.45
    CRP (mg/L) 97.2 [41.8, 165.3] 95.27 [31.6, 161.8] 132.9 [72.8, 193.1] 0.116
    PCT (μg/L) 1.8 [1.3, 2.4] 1.80 [1.30, 2.52] 1.75 [1.33, 2.28] 0.537
    IL-6 (pg/mL) 76.4 [22.7, 319.0] 69.1 [20.5, 301.2] 145[54.3, 476.0] 0.09
    NT-proBNP (pg/mL) 2379 [658, 9777] 2205 [632, 9487] 3927 [1198, 10783] 0.128
Fluid balanceb
    Output (mL) 6356 [4603, 8436] 6374 [4602, 8412] 6356 [4788, 9312] 0.582
    Intput (mL) 8358 [6373, 10368] 8320 [6361, 10162] 8816 [6460, 11635] 0.417
    Volume (mL) 1470 [-113, 3718] 1420 [-92, 3739] 1521 [-179, 3661] 0.81
    Mechanical ventilation [n (%)] 138(75.0) 104(69.3) 34(100.0) < 0.001
Treatmentb
    Prone ventilation [n (%)] 44(25.4) 30(21.6) 14(41.2) 0.033
    Vasopressor use [n (%)] 135(84.4) 103(81.7) 32(94.1) 0.134
    CRRT [n (%)] 86(47.5) 65(44.2) 21(61.8) 0.098
    ECMO [n (%)] 9(4.9) 5(3.4) 4(11.8) 0.111
Transitions
    Hospitalization [n (%)] 36(18.1) 35(21.3) 1(2.9)
    Discharge [n (%)] 67(33.7) 53(32.3) 14(40.0)
    Death [n (%)] 96(48.2) 76(46.3) 20(57.1)